Phase 2 Study of Daxdilimab with Prednisone in Adults with Inadequately Controlled Dermatomyositis or Anti‑Synthetase Inflammatory Myositis
GermanyA study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe
GermanyA Study of Cizutamig for Patients with Severe Autoimmune Inflammatory Diseases That Did Not Respond to Previous Treatments
GermanyTitle: Long-term safety and effectiveness study of ulviprubart in patients with inclusion body myositis who completed previous treatment
GermanyStudy on the Effectiveness and Safety of Losmapimod for Patients with Facioscapulohumeral Muscular Dystrophy (FSHD)
GermanyStudy on the Safety and Effects of Delandistrogene Moxeparvovec in Children Under 4 with Duchenne Muscular Dystrophy
GermanyStudy on AOC 1001 for Treating Myotonic Dystrophy Type 1 in Patients
GermanyStudy on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy
GermanyStudy on Eteplirsen for Patients with Duchenne Muscular Dystrophy with Deletion Mutations Amenable to Exon 51 Skipping
GermanyStudy on the Effects of Ribitol (BBP-418) in Patients with Limb Girdle Muscular Dystrophy Type 2I
GermanySafety and effectiveness study of DYNE-101 in patients with Myotonic Dystrophy Type 1 (DM1)
GermanyStudy to Determine the Best Dose of Vesleteplirsen for Patients with Duchenne Muscular Dystrophy Suitable for Exon 51-Skipping Treatment
Germanypowered by
